Alpha Teknova Files S-1 for Public Offering

TL;DR

Alpha Teknova just filed an S-1, looks like they're gearing up for an IPO/offering.

AI Summary

Alpha Teknova, Inc. filed an S-1 form on August 23, 2024, to register securities for public sale. The company, incorporated in Delaware, is based in Hollister, California, and operates in the in vitro & in vivo diagnostic substances sector. Stephen Gunstream is the President and CEO.

Why It Matters

This S-1 filing indicates Alpha Teknova, Inc. is preparing to offer its securities to the public, which could lead to significant capital infusion and increased trading activity.

Risk Assessment

Risk Level: medium — As an S-1 filing, it signifies a company preparing for a public offering, which inherently carries market and execution risks.

Key Numbers

• 0001850902 — Central Index Key (Unique identifier for Alpha Teknova, Inc. in SEC filings.)
• 943368109 — IRS Employer Identification Number (Tax identification number for Alpha Teknova, Inc.)

Key Players & Entities

• Alpha Teknova, Inc. (company) — Registrant
• August 23, 2024 (date) — Filing Date
• Delaware (jurisdiction) — State of Incorporation
• Hollister, CA (location) — Business Address
• Stephen Gunstream (person) — President and Chief Executive Officer
• 333-281765 (registration_number) — SEC File Number

FAQ

Key Financial Figures

• $0.00001 — any, Teknova, we, us or our), par value $0.00001 per share (the common stock), issued by
• $4.92 — n stock on the Nasdaq Global Market was $4.92 per share. See the section titled Ris
• $10,000 — 96% for customers purchasing more than $10,000 annually, which represented approximate
• $1.24 — ur common stock at an offering price of $1.24 per Share. Our controlling stockholde
• $15.4 million — gregate gross proceeds of approximately $15.4 million from the Offering, before deducting off

Filing Documents

• d831664ds1.htm (S-1) — 272KB
• d831664dex51.htm (EX-5.1) — 15KB
• d831664dex231.htm (EX-23.1) — 2KB
• d831664dexfilingfees.htm (EX-FILING FEES) — 32KB
• g831664dsp041.jpg (GRAPHIC) — 9KB
• g831664dsp41.jpg (GRAPHIC) — 4KB
• g831664dsp41a.jpg (GRAPHIC) — 9KB
• g831664g0821064653594.jpg (GRAPHIC) — 3KB
• g831664g0821064653835.jpg (GRAPHIC) — 30KB
• 0001193125-24-206239.txt ( ) — 398KB

Risk Factors

Risk Factors 6 Market and Industry Data 7

Use of Proceeds

Use of Proceeds 8 Dividend Policy 9 Determination of Offering Price 10 Selling Stockholders 11 Plan of Distribution 13

Description of Capital Stock

Description of Capital Stock 15 Legal Matters 21 Experts 21 Change in Auditor 21 Where You Can Find Additional Information 22 Incorporation of Certain Information by Reference 23 i Table of Contents ABOUT THIS PROSPECTUS This prospectus relates to the resale by the Selling Stockholders identified in this prospectus under the caption Selling Stockholders , from time to time, of an aggregate of 12,385,883 shares of common stock. We are not selling any shares of common stock under this prospectus, and we will not receive any proceeds from the sale of shares of common stock offered hereby by the Selling Stockholders. You should rely only on the information provided in this prospectus, including any information incorporated by reference. We have not authorized anyone to provide you with any other information and we take no responsibility for, and can provide no assurances as to the reliability of, any other information that others may give you. The information contained in this prospectus speaks only as of the date set forth on the cover page and may not reflect subsequent changes in our business, financial condition, results of operations and prospects. We are not, and the Selling Stockholders are not, making offers to sell these securities in any jurisdiction in which an offer or solicitation is not authorized or permitted or in which the person making such offer or solicitation is not qualified to do so or to any person to whom it is unlawful to make such an offer or solicitation. You should read this prospectus, including any information incorporated by reference, in its entirety before making an investment decision. You should also read and consider the information in the documents to which we have referred you in the sections entitled Where You Can Find Additional Information and Incorporation of Certain Information by Reference . ii Table of Contents CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This prospectus and

executive compensation or golden parachute arrangements

executive compensation or golden parachute arrangements. In addition, under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have elected to avail ourselves of this exemption from adopting new or revised accounting standards, and, therefore, we will not be those of other public companies more difficult. We may take advantage of these reporting exemptions until we no longer qualify as an emerging growth company, or, with respect to adoption of certain new or revised accounting standards, until we irrevocably elect to opt

View Full Filing

View this S-1 filing on SEC EDGAR